Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent Tuberculosis

NCT06618573 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT06618573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06618573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent Tuberculosis
Lead sponsor
Universitas Padjadjaran
Phase
Phase 2/3
Overall status
Recruiting
Start date
August 15, 2022
Completion date
December 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus, tuberculosis